Post-approval studies (Phase 4)Ended earlyNCT00522548
What this trial is testing
Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients
Who this might be right for
Transplants and Implants
University of Pennsylvania 37
Showing 9 of 9 results